West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 20.18%

West Pharmaceutical Services, Inc. EBIT Margin is 20.18% for the Trailing 12 Months (TTM) ending June 30, 2025, a -6.04% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 21.48%, a 0.05% change year over year.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 21.47%, a -19.71% change year over year.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 26.74%, a 11.09% change year over year.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 24.07%, a 38.11% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin